A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.

Overview of attention for article published in Journal of Clinical Oncology, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 6 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 47,272 followers.

RT @pashtoonkasi: #TumorBoardTuesday we also have the 1st line study 📚 looking at ascorbate alongside Gem/Nab-P; makes it easier for me to…

RT @DrBonillaOnc: @heatherahannon @TumorBoardTues @pashtoonkasi @SyedAAhmad5 @NirajGusani @OncoAlert @oncologician @BenWestphalen @Aiims174…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.